Brachytherapy Market Introduction and Overview
According to SPER Market Research, the Global Brachytherapy Market is estimated to reach USD 1.98 billion by 2033 with a CAGR of 7.56%.
The report includes an in-depth analysis of the Global Brachytherapy market, including market size and trends, product mix, distribution channels, and supplier analysis. Brachytherapy is preferred over other types of radiation therapy equipment for cancer treatment because patients treated with it have a lower risk of relapse. Other modern brachytherapy techniques (PDR) include Image Guided Brachytherapy (IGBT) and Pulse Dose Rate. Brachytherapy is now enabled by programming agreements, which allow medical service providers to legally deliver and schedule brachytherapy for patients.
- Global brachytherapy market expansion the growth in the prevalence of cancer, the increase in the number of senior populations, and the rise in the prevalence of cancer are the primary drivers of the Brachytherapy Market Size. Brachytherapy is mostly used in cancer treatment. For example, according to World Cancer Research Fund International figures from 2020, there were an anticipated 18.1 million cancer cases worldwide.
Market Opportunities and Challenges
The brachytherapy industry offers a variety of opportunities and difficulties in the field of medical technology and cancer treatment. Brachytherapy, a type of localized radiation therapy, has a number of intriguing applications. For starters, it offers a more tailored approach to treating specific tumors, avoiding damage to healthy surrounding tissues and lowering side effects. This accuracy has the potential to improve patient outcomes and quality of life. Furthermore, advances in imaging technologies and treatment planning software have improved the precision and customisation of brachytherapy operations, allowing it to be applied to a broader spectrum of cancer types. Furthermore, growing knowledge of the benefits of minimally invasive therapies has increased interest in brachytherapy, which frequently needs shorter hospital stays and recovery times than standard surgery.
However, the brachytherapy market faces a number of challenges. Market expansion can be hampered by regulatory clearances and reimbursement rules. Another critical difficulty is ensuring sufficient training for healthcare personnel to perform brachytherapy operations safely and successfully. Furthermore, the initial capital expenditure required for the requisite equipment and infrastructure can be significant, limiting availability in some healthcare settings. Other sophisticated cancer treatments, such as external beam radiation therapy and immunotherapy, compete for market share.
-009310622082023.jpg)
Market Competitive Landscape
Competitive analyses and profiles of the key brachytherapy market participants include Argon Medical, Carl Zeiss AG, Eckert & Ziegler BEBIG, Elekta AB, Icad, Inc., Isoaid, Isoray Medical, Inc, Merit Medical Systems, Inc, Siemens AG, and Theragenics Corporation are some of the key firms operating in the worldwide brachytherapy industry. Siemens AG, Elekta AB, and others are among the market's major participants. To improve the brachytherapy market's product portfolio, major players have used product launch, product growth, and acquisition as significant development tactics.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2033 |
| Base year considered | 2022 |
| Forecast period | 2023-2033 |
| Segments covered | By Product, By Dosage Type, By End User, By Application.
|
| Regions covered | North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.
|
| Companies Covered | Argon Medical Devices, Becton, Best Vascular, Carl Zeiss Meditec AG, CIVCO MEDICAL SOLUTIONS, Dickinson and Company, Eckert & Zieglet BEBIG A.G, Elekta AB, iCAD Inc, Isoray Inc, Panacea Medical Technology Pvt. Ltd., RadiaDyne, SUN NUCLEAR CORPORATION, Theragenics Corporation, VARIAN MEDICAL SYSTEMS, Inc.
|
COVID-19 Impact on Global Brachytherapy Market
The COVID-19 epidemic has had a substantial influence on global healthcare systems, as well as the market for brachytherapy equipment. According to a study published last year titled "The Impact of COVID-19 on Brachytherapy," advances in radiation oncology allowed six patients with unfavorable intermediate- and high-risk diseases to elect to receive EBRT followed by a brachytherapy boost, and four patients were treated with brachytherapy instead because elective surgeries had to be postponed within the system due to the pandemic. Despite the problems the healthcare system faced throughout the outbreak, the majority of cancer patients were safely treated with only minor treatment delays and disruptions.
Key Target Audience
- Oncologists and Radiation Oncologists
- Medical Institutions and Hospitals
- Medical Device Manufacturers
- Radiation Therapists and Medical Physicists
Our in-depth analysis of the Brachytherapy Market includes the following segments:
|
By Product:
|
Applicators & Afterloaders
Electronic Brachytherapy
Seeds
|
|
By Dosage Type:
|
High-Dose Rate (HDR)Brachytherapy
Low-Dose Rate (LDR)Brachytherapy
|
|
By Application:
|
Breast Cancer
Gynecological Cancer
Prostate Cancer
Others
|
|
By End-User:
|
Hospitals
Specialty Clinics
Others
|
Key Topics Covered in the Report
- Global Brachytherapy Market Size (FY’2023-FY’2033)
- Overview of Global Brachytherapy Market
- Segmentation of Global Brachytherapy Market By Product (Applicators & Afterloaders, Electronic Brachytherapy, Seeds)
- Segmentation of Global Brachytherapy Market By Dosage (High-Dose Rate (HDR)Brachytherapy, Low-Dose Rate (LDR)Brachytherapy)
- Segmentation of Global Brachytherapy Market By Application (Breast Cancer, Gynecological Cancer, Prostate Cancer, Others)
- Segmentation of Global Brachytherapy Market By End User (Hospitals, Specialty Clinics, Others)
- Statistical Snap of Global Brachytherapy Market
- Expansion Analysis of Global Brachytherapy Market
- Problems and Obstacles in Global Brachytherapy Market
- Competitive Landscape in the Global Brachytherapy Market
- Impact of COVID-19 and Demonetization on Global Brachytherapy Market
- Details on Current Investment in Global Brachytherapy Market
- Competitive Analysis of Global Brachytherapy Market
- Prominent Players in the Global Brachytherapy Market
- SWOT Analysis of Global Brachytherapy Market
- Global Brachytherapy Market Future Outlook and Projections (FY’2023-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Global Brachytherapy Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Brachytherapy Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Brachytherapy Market
7. Global Brachytherapy Market, By Product (USD Million)
7.1. Global Brachytherapy Market Value Share and Forecast, By Product, 2023-2033
7.2. Applicators & Afterloaders
7.3. Electronic Brachytherapy
7.4. Seeds
8. Global Brachytherapy Market, By Dosage Type (USD Million)
8.1. Global Brachytherapy Market Value Share and Forecast, By Dosage Type, 2023-2033
8.2. High-Dose Rate (HDR)Brachytherapy
8.3. Low-Dose Rate (LDR)Brachytherapy
9. Global Brachytherapy Market, By Application (USD Million)
9.1. Global Brachytherapy Market Value Share and Forecast, By Application, 2023-2033
9.2. Breast Cancer
9.3. Gynaecological Cancer
9.4. Prostate Cancer
9.5. Others
10. Global Brachytherapy Market, By End User (USD Million)
10.1. Global Brachytherapy Market Value Share and Forecast, By End User, 2023-2033
10.2. Hospitals
10.3. Speciality Clinic
10.4. Others
11. Global Brachytherapy Market Forecast, 2019-2033 (USD Million)
11.1. Global Brachytherapy Market Size and Market Share
12. Global Brachytherapy Market, By Product, 2019-2033 (USD Million)
12.1. Global Brachytherapy Market Size and Market Share By Product (2019-2026)
12.2. Global Brachytherapy Market Size and Market Share By Product (2027-2033)
13. Global Brachytherapy Market, By Dosage Type, 2019-2033 (USD Million)
13.1. Global Brachytherapy Market Size and Market Share By Dosage Type (2019-2026)
13.2. Global Brachytherapy Market Size and Market Share By Dosage Type (2027-2033)
14. Global Brachytherapy Market, By Application, 2019-2033 (USD Million)
14.1. Global Brachytherapy Market Size and Market Share By Application (2019-2026)
14.2. Global Brachytherapy Market Size and Market Share By Application (2027-2033)
15. Global Brachytherapy Market, By End User, 2019-2033 (USD Million)
15.1. Global Brachytherapy Market Size and Market Share By End User (2019-2026)
15.2. Global Brachytherapy Market Size and Market Share By End User (2027-2033)
16. Global Brachytherapy Market, By Region, 2019-2033 (USD Million)
16.1. Global Brachytherapy Market Size and Market Share By Region (2019-2026)
16.2. Global Brachytherapy Market Size and Market Share By Region (2027-2033)
16.3. Asia-Pacific
16.3.1. Australia
16.3.2. China
16.3.3. India
16.3.4. Japan
16.3.5. South Korea
16.3.6. Rest of Asia-Pacific
16.4. Europe
16.4.1. France
16.4.2. Germany
16.4.3. Italy
16.4.4. Spain
16.4.5. United Kingdom
16.4.6. Rest of Europe
16.5. Middle East and Africa
16.5.1. Kingdom of Saudi Arabia
16.5.2. United Arab Emirates
16.5.3. Rest of Middle East & Africa
16.6. North America
16.6.1. Canada
16.6.2. Mexico
16.6.3. United States
16.7. Latin America
16.7.1. Argentina
16.7.2. Brazil
16.7.3. Rest of Latin America
17. Company Profile
17.1. Argon Medical Devices
17.1.1. Company details
17.1.2. Financial outlook
17.1.3. Product summary
17.1.4. Recent developments
17.2. Becton
17.2.1. Company details
17.2.2. Financial outlook
17.2.3. Product summary
17.2.4. Recent developments
17.3. Best Vascular, Inc
17.3.1. Company details
17.3.2. Financial outlook
17.3.3. Product summary
17.3.4. Recent developments
17.4. Carl Zeiss Meditec AG
17.4.1. Company details
17.4.2. Financial outlook
17.4.3. Product summary
17.4.4. Recent developments
17.5. CIVCO MEDICAL SOLUTIONS
17.5.1. Company details
17.5.2. Financial outlook
17.5.3. Product summary
17.5.4. Recent developments
17.6. Dickinson and Company
17.6.1. Company details
17.6.2. Financial outlook
17.6.3. Product summary
17.6.4. Recent developments
17.7. Eckert & Ziegler BEBIG S.A
17.7.1. Company details
17.7.2. Financial outlook
17.7.3. Product summary
17.7.4. Recent developments
17.8. Elekta AB.
17.8.1. Company details
17.8.2. Financial outlook
17.8.3. Product summary
17.8.4. Recent developments
17.9. iCAD Inc
17.9.1. Company details
17.9.2. Financial outlook
17.9.3. Product summary
17.9.4. Recent developments
17.10. Isoray Inc
17.10.1. Company details
17.10.2. Financial outlook
17.10.3. Product summary
17.10.4. Recent developments
17.11. Others
18. List of Abbreviations
19. Reference Links
20. Conclusion
21. Research Scope